173 related articles for article (PubMed ID: 28965468)
1. Misleading Guidance From Pharmacogenomic Testing.
Rahman T; Ash DM; Lauriello J; Rawlani R
Am J Psychiatry; 2017 Oct; 174(10):922-924. PubMed ID: 28965468
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
Sriretnakumar V; Huang E; Müller DJ
Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of antipsychotic treatment in schizophrenia.
Pouget JG; Müller DJ
Methods Mol Biol; 2014; 1175():557-87. PubMed ID: 25150876
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model.
Perlis RH; Ganz DA; Avorn J; Schneeweiss S; Glynn RJ; Smoller JW; Wang PS
J Clin Psychopharmacol; 2005 Oct; 25(5):427-34. PubMed ID: 16160617
[TBL] [Abstract][Full Text] [Related]
6. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics and schizophrenia: clinical implications.
Malhotra AK
Pharmacogenomics J; 2001; 1(2):109-14. PubMed ID: 11911437
[No Abstract] [Full Text] [Related]
8. Precise pharmacogenetic pharmacometabolomic (PPP) guided clozapine therapy in treatment resistant schizophrenia: Insights from one ethnicity experiment.
Patil AN; Kasudhan KS; Naveen M; Batra GK; Chakrabarti S; Avasthi A; Grover S
Schizophr Res; 2021 Nov; 237():26-28. PubMed ID: 34481201
[No Abstract] [Full Text] [Related]
9. Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine.
Spencer BW; Prainsack B; Rujescu D; Giegling I; Collier DA; Gaughran F; MacCabe JH; Barr CL; Sigurdsson E; Stovring H; Malhotra AK; Curran SR;
Pharmacogenomics; 2013 Nov; 14(15):1907-14. PubMed ID: 24236489
[TBL] [Abstract][Full Text] [Related]
10. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of antipsychotics: recent progress and methodological issues.
Zhang JP; Malhotra AK
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):183-91. PubMed ID: 23199282
[TBL] [Abstract][Full Text] [Related]
12. Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.
Huang E; Maciukiewicz M; Zai CC; Tiwari AK; Li J; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Kennedy JL
Pharmacogenomics; 2016; 17(2):103-9. PubMed ID: 26666695
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.
Elsheikh SSM; Müller DJ; Pouget JG
Methods Mol Biol; 2022; 2547():389-425. PubMed ID: 36068471
[TBL] [Abstract][Full Text] [Related]
14. Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection.
Bousman CA; Zierhut H; Müller DJ
Clin Pharmacol Ther; 2019 Aug; 106(2):309-312. PubMed ID: 31004441
[No Abstract] [Full Text] [Related]
15. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
16. Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia.
Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
Pharmacogenet Genomics; 2010 Apr; 20(4):274-6. PubMed ID: 20168265
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics of antipsychotics in schizophrenia].
Méary A
Therapie; 2008; 63(3):243-6. PubMed ID: 18718213
[TBL] [Abstract][Full Text] [Related]
18. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes.
Souza RP; de Luca V; Meltzer HY; Lieberman JA; Kennedy JL
Int J Neuropsychopharmacol; 2010 Jul; 13(6):793-8. PubMed ID: 20196918
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of the clozapine response.
Schumacher J; Schulze TG; Wienker TF; Rietschel M; Nöthen MM
Lancet; 2000 Aug; 356(9228):506-7. PubMed ID: 10981913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
